Swetha Kaul currently serves as the Chief Scientific Officer at Cannalysis, a state licensed ISO/IEC 17025 accredited cannabis testing laboratory that seeks to empower customers through technology integrations, big data analytics and access to information.
Prior to joining Cannalysis, Swetha worked at Allergan where she was responsible for drug development efforts including analytical method development, formulation research, stability studies, new process development, and optimization of processes.
Swetha brings more than a decade of technical and leadership experience from academia and the pharmaceutical industry to the emerging field of cannabis testing. Her experience working in the highly regulated pharmaceutical industry provides valuable insight into the rigorous scientific practices required for compliance. Her experience presenting scientific concepts and data to various audiences has proven to be a valuable tool in the cannabis industry. She has authored several white papers and has been on numerous panels discussing scientific methods and regulations relating to laboratory testing within the industry. As a member of the CCIA Board of Directors and Chair of the Quality Control Committee, Swetha is committed to educating the general public about the science behind testing procedures and legitimizing the cannabis industry by setting a high bar for scientific integrity.